Related Experiment Video

Updated: Jul 29, 2025

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma
08:00

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

18.2K

[Access and safety of dexamethasone in multiple myeloma patients]

Florian Slimano1, Jean-François Tournamille2, Christophe Bardin3

  • 1CHU de Reims, université de Reims Champagne-Ardenne, BioSpecT, pharmacie, 51100 Reims, France; Société française de pharmacie oncologique (SFPO), Paris, France.

Bulletin Du Cancer
|May 24, 2023
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

8.7K
Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

6.9K

Related Experiment Videos

Last Updated: Jul 29, 2025

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma
08:00

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

18.2K
An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

8.7K
Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

6.9K

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

1.7K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.7K

Articles linked to this work by shared authors, journal, and citation graph.

AI adoption among French oncology pharmacists: A national survey.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2026

Daratumumab, lenalidomide, and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: MAIA final survival analysis.

Leukemia·2026

Blood-based MALDI-TOF mass spectrometry versus bone marrow MRD for monitoring multiple myeloma: CASSIOPEIA study results.

Blood·2026

Ultra-low temperature storage of advanced therapy medicinal products in hospital pharmacies: findings from a national survey of French hospital pharmacists.

European journal of hospital pharmacy : science and practice·2026

Characterization of the Migration Profile of 36 Therapeutic Monoclonal Antibodies in Serum Protein Electrophoresis and Immunofixation.

Clinical chemistry·2026

Real-World Evidence of Immunotherapy Sequencing in Multiple Myeloma: Durable Responses With BCMA-Targeting Bispecific Antibodies Following Prior GPRC5D-Targeting Therapy.

Clinical lymphoma, myeloma & leukemia·2026

Hospitalization at home use analysis for immune checkpoint inhibitors administrations in France: Care pathways, costs and development opportunities.

Bulletin du cancer·2026

[Oncogenetics and molecular tumor boards in private practice: Specificities and perspectives].

Bulletin du cancer·2026

Targeting TP53 in triple-negative breast cancer: Molecular pathogenesis, therapeutic implications, and emerging pharmacological strategies.

Bulletin du cancer·2026

French treatment recommendations for malignant non-seminomatous germ cell tumours in children and adolescents.

Bulletin du cancer·2026

A comprehensive review on the molecular basis and therapeutic potential of UBE2M in cancer.

Bulletin du cancer·2026

Cervical cancer in French Guiana before the implementation of the University Hospital: Outcome and prognosis.

Bulletin du cancer·2026

Are Urooncologists Onboard?

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

The State of the Art of Theranostics and Its Future.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

[Alzheimer's disease: scientific advances, diagnostic challenges and therapeutic perspectives].

Soins; la revue de reference infirmiere·2026

Photobiomodulation therapy and the regulation of excitation-inhibition balance in neurological and psychiatric disorders: Mechanistic and translational perspectives.

Neuroscience·2026

Threshold Price of Belantamab for Relapsed/Refractory Multiple Myeloma in China: A Cost-Effectiveness Analysis.

PharmacoEconomics - open·2026

MiR-590-3p Targets HMGB1 to Alleviate Endothelial Injury Induced by β2GPI/Anti-β2GPI Immune Complex.

International journal of immunogenetics·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us